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Purpose: Stroke is a serious complication after acute myocardial infarction
(AMI) and is closely associated with poor prognosis. This study aimed to
investigate the frequency, the characteristics and factors associated with in-
hospital and postdischarge stroke in patients with AMI. 
Methods: 8485 consecutive patients admitted in intensive care unit (ICU)
between January 2001 and June 2010 were included. Among other major
adverse cardiac events (MACE), both stroke and transient ischemic attack
(TIA) were collected during one-year follow-up. 
Results: 168 (1.98%) strokes were recorded during the first year of follow-up
after AMI. In-hospital strokes (IHS) occurred in 123 patients (1.4%), and 87% of
them in the first five days after admission in ICU. After multivariate logistic
regression analysis, IHS was independently associated with female sex (OR: 1.73,
95% CI: 1.19-2.51, p=0.004), previous stroke/TIA (OR: 2.21, 95% CI: 1.28-3.83,
p=0.004), LVEF (OR: 0.96, 95% CI: 0.95-0.98, p<0.001), new onset atrial fibril-
lation (AF) (OR: 1.99, 95% CI: 1.25-3.16, p=0.004) and C-reactive protein (CRP)
(OR 1.006, 95% CI: 1,003-1,009, p<0.001). Patients developing an in-hospital
stroke had an increased risk of death at one year after adjustment to other prog-
nostic factors (OR: 1.82, 95% CI: 1.05-3.15, p=0.031). Among surviving patients
(n=7808), postdischarge stroke (PDS) occurred in 45 patients (0.64%) within one-
year follow-up after AMI. After multivariate logistic regression analysis, PDS
was independently associated with age (OR: 1.04, 95% CI: 1.01-1.07, p=0.003),
previous stroke/TIA (OR: 3.69, 95% CI: 1.83-7.43, p<0.001) and systemic hyper-
tension (OR: 2.77, 95% CI: 1.26-6.08, p=0.011). During the entire study period
of ten years, the annual rate of stroke post-AMI remained stable. 
Conclusions: The present study describes specific predictors of in-hospital
and postdischarge stroke in patients with AMI, with a marked increase in the
risk of death, both during hospitalization and the year after AMI. After hos-
pital discharge, stroke remains a rare event and mostly associated with a high
cardiovascular risk.
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Background: Coronary Artery Anomalies (CAA), including anomalies of
coronary origin (ANOCOR) and ectasia or coronary aneurysms (ECTACOR)
share common entities. In coronary angiographies or autopsy series, their
prevalence range from 0.2 to 1.5%. Case control studies reported an associa-
tion between CAA and acute myocardial infarction (MI). We aimed to analyze
their prevalence, characteristics, therapeutic strategies and prognosis in
patients with acute MI.
Methods: All the consecutive patients admitted in the intensive care unit
of our hospital who underwent coronary angiography for an acute MI from
2001 to 2013 were retrospectively analysed. 
Results: Among the 9393 patients included during the study period,
80(0.92%) CAA were identified, including 37 (46%), ANOCOR and 43 (54%)
ECTACOR. Most were male (86%), with a mean age at 61±14 y, and 2.1±1.4
risk factors. The most frequent localisation of ANOCOR was the circumflex
artery (65%). The abnormal artery corresponds to the culprit lesion in 30% of
cases, and 46% had significant stenosis. In contrast, ECTACOR were mainly
localised on the right coronary artery (58%), and correspond to the culprit
lesion in 70% of the cases, and 60% had a significant stenosis. A minority, i.e.
41% of the significant lesions found on ANOCOR and 31% of those on
ECTACOR, received only a medical treatment, while 47% and 58% were
stented, or 12% and 12% underwent Coronary Artery Bypass Surgery, respec-
tively. After Percutaneous Coronary Intervention (PCI), final flow was TIMI
3 in most cases (94% and 81%, respectively). Only one patient died during the
hospital stay.
Conclusion: In our large retrospective study, the prevalence of CAAs is
consistent with older angiographic series. Culprit lesion was more frequently
associated with ECTACOR, but not with ANOCOR. The majority of signifi-
cant lesions was treated by coronary stenting with a successful angiographic
result.
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Background: Contrast-induced nephropathy (CIN) is a frequent complica-
tion in patients undergoing percutaneous coronary intervention (PCI), associ-
ated with increased mortality. The impact of metformin, which has potential
interactions with renal function, on CIN remains to be investigated.
Aim: To analyze the association between chronic metformin treatment and
the development of CIN after primary PCI for ST segment elevation myocar-
dial infarction (STEMI).
Methods: 372 patients with diabetes mellitus (DM) treated with PCI <24H
in 2 coronary care units (Paris-Bichat and Dijon Hospital, France) were
included. Serum creatinine (Cr) was measured before and 48H after PCI. CIN
was defined as an increase in Cr of 44μmol/L (0.5mg/dL) or 25% over base-
line after PCI. Since PCI was urgent, metformin could not be withheld prior
to PCI but was usually stopped after PCI. 
Results: Mean age was 66±11 y, and 25% were women. 64% had hyper-
tension, 56% had DM duration > 5 year, and 26% had prior coronary artery
disease. Metformin and sulfonylurea were the most frequently used anti-
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